Myeloproliferative Neoplasms—Health Professional Version

Myelodysplastic Syndromes Treatment (PDQ®)

Myelodysplastic syndromes (MDS) treatment options include supportive care, disease-modifying agents, and allogeneic stem cell transplant. Get detailed information about the treatment of newly diagnosed and recurrent MDS in this summary for clinicians.

Myeloproliferative Neoplasms Treatment (PDQ®)

Myeloproliferative neoplasms (MPN) treatment varies widely depending on the specific diagnosis. Treatment options may include observation, phlebotomy, steroids, chemotherapy, immunotherapy, and stem cell transplant.

Myelodysplastic/ Myeloproliferative Neoplasms Treatment (PDQ®)

Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are treated with chemotherapy or other drugs, stem cell transplant, supportive care, and targeted therapy. Learn about the clinical features and treatment options for these conditions.

Childhood Acute Myeloid Leukemia Treatment (PDQ®)

Treatments for children with acute myeloid leukemia (AML) include combination chemotherapy, stem cell transplant, and targeted therapy. Other drug therapy and supportive care are also used. Get detailed information for AML in this clinician summary.

Drugs Approved for Myeloproliferative Neoplasms or Myelodysplastic Syndromes

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for myeloproliferative neoplasms or myelodysplastic syndromes. The list includes generic names, brand names, and common drug combinations, which are shown in capital letters.

DDX41-Associated Myeloid Malignancies

DDX41-Associated Myeloid Malignancies is a hereditary hematologic malignancy syndrome associated with the DDX41 gene. Learn about DDX41's clinical features and management.

RUNX1-Familial Platelet Disorder

RUNX1-familial platelet disorder (RUNX1-FPD) is a hereditary hematologic malignancy syndrome associated with the RUNX1 gene. Learn about RUNX1-FPD’s clinical features and management.

GATA2 Deficiency Syndrome

GATA2 deficiency syndrome is a hereditary hematologic malignancy syndrome associated with the GATA2 gene. Learn about GATA2's clinical features and management.

Genetics of Hereditary Hematologic Malignancies

Genetics of Hereditary Hematologic Malignancies includes the hereditary cancer syndromes and genes associated with hematologic malignancies. Get comprehensive information about hereditary hematologic malignancies in this clinician summary.